Chair: Kazuo Fujihara (Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience)
Clinical Significance of MOG-IgG Assay in MOGAD Diagnosis and Latest Understanding of Pathophysiology
Fabienne Brilot (The University of Sydney – Sydney, Australia)
Pathology of MOGAD
Yoshiki Takai (Department of Neurology, Tohoku University Graduate School of Medicine, Department of Pathology, Tohoku University Hospital – Sendai, Japan)